These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 17520785)
1. Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism. Yi PL; Tsai CH; Lu MK; Liu HJ; Chen YC; Chang FC Sleep; 2007 Apr; 30(4):413-25. PubMed ID: 17520785 [TBL] [Abstract][Full Text] [Related]
2. TNF-NF-kappaB signaling mediates excessive somnolence in hemiparkinsonian rats. Lu CY; Yi PL; Tsai CH; Cheng CH; Chang HH; Hsiao YT; Chang FC Behav Brain Res; 2010 Apr; 208(2):484-96. PubMed ID: 20043954 [TBL] [Abstract][Full Text] [Related]
3. Kindling stimuli delivered at different times in the sleep-wake cycle. Yi PL; Tsai CH; Lin JG; Lee CC; Chang FC Sleep; 2004 Mar; 27(2):203-12. PubMed ID: 15124712 [TBL] [Abstract][Full Text] [Related]
4. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms]. Šaponjić J Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729 [TBL] [Abstract][Full Text] [Related]
5. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings. von Wrangel C; Schwabe K; John N; Krauss JK; Alam M Behav Brain Res; 2015 Feb; 279():52-61. PubMed ID: 25446762 [TBL] [Abstract][Full Text] [Related]
6. Sleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 beta receptor 1 and tumor necrosis factor-alpha receptor 1. Baracchi F; Opp MR Brain Behav Immun; 2008 Aug; 22(6):982-93. PubMed ID: 18329246 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1beta has a role in cerebral cortical state-dependent electroencephalographic slow-wave activity. Yasuda T; Yoshida H; Garcia-Garcia F; Kay D; Krueger JM Sleep; 2005 Feb; 28(2):177-84. PubMed ID: 16171241 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effects of Eexenatide in a Rotenone-Induced Rat Model of Parkinson's Disease. Aksoy D; Solmaz V; Çavuşoğlu T; Meral A; Ateş U; Erbaş O Am J Med Sci; 2017 Sep; 354(3):319-324. PubMed ID: 28918840 [TBL] [Abstract][Full Text] [Related]
9. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats. Alam M; Danysz W; Schmidt WJ; Dekundy A Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571 [TBL] [Abstract][Full Text] [Related]
10. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990 [TBL] [Abstract][Full Text] [Related]
12. Interplay of dopamine and GABA in substantia nigra for the regulation of rapid eye movement sleep in rats. Yadav RK; Khanday MA; Mallick BN Behav Brain Res; 2019 Dec; 376():112169. PubMed ID: 31442548 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease. Thakur P; Nehru B Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314 [TBL] [Abstract][Full Text] [Related]
14. [Effect of electroacupuncture intervention on ERK 1/2 signaling and TNF-α and IL-1β protein levels in the substantia Nigra in rats with Parkinson's Disease]. Wang SJ; Ma J; Gong YX; Wang YC; Zeng XL; Liang Y; Sun GJ Zhen Ci Yan Jiu; 2014 Dec; 39(6):456-60. PubMed ID: 25632569 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of evening primrose oil on behavioral activities, nigral microglia and histopathological changes in a rat model of rotenone-induced parkinsonism. Mohammad HMF; El-Baz AA; Mahmoud OM; Khalil S; Atta R; Imbaby S J Chem Neuroanat; 2023 Jan; 127():102206. PubMed ID: 36464068 [TBL] [Abstract][Full Text] [Related]
16. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Alam M; Schmidt WJ Behav Brain Res; 2004 Aug; 153(2):439-46. PubMed ID: 15265640 [TBL] [Abstract][Full Text] [Related]
17. REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson's disease. Dos Santos AC; Castro MA; Jose EA; Delattre AM; Dombrowski PA; Da Cunha C; Ferraz AC; Lima MM J Neurosci Res; 2013 Nov; 91(11):1508-16. PubMed ID: 23908011 [TBL] [Abstract][Full Text] [Related]
18. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats. Lin CH; Huang JY; Ching CH; Chuang JI J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173 [TBL] [Abstract][Full Text] [Related]
19. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation. Zhou F; Wu JY; Sun XL; Yao HH; Ding JH; Hu G Neuropsychopharmacology; 2007 Dec; 32(12):2570-80. PubMed ID: 17356569 [TBL] [Abstract][Full Text] [Related]
20. GABA in pedunculopontine tegmentum increases rapid eye movement sleep in freely moving rats: possible role of GABA-ergic inputs from substantia nigra pars reticulata. Pal D; Mallick BN Neuroscience; 2009 Dec; 164(2):404-14. PubMed ID: 19698764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]